跳至主要内容
临床试验/CTRI/2018/06/014642
CTRI/2018/06/014642招募中2 期

Evaluation of Therapeutic Efficacy and Safety of coded Unani Drugs PTH-1, PTH-2 and PTH-3 in Asymptomatic Hepatitis B Carriers

DG Central Council for Research in Unani Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Subjects of any Gender aged 20-60 years
  • 2. HBsAg-Positive Asymptomatic Cases
  • 3. Viral Load <20,000 IU/mL

排除标准

  • 1. Viral Load: >20,000 IU/mL
  • 2. Active Hepatitis
  • 3. Patients on Immune Suppressants Therapy
  • 4. History of Severe Systemic Disease
  • 5. H/o of Drug or Alcohol Abuse, Chronic Smokers not willing to abstain from smoking during the study period
  • 6. Subjects with known allergies
  • 7. Receiving any other Investigational Product

研究者

发起方
DG Central Council for Research in Unani Medicine

相似试验